Last Seen Blogs
suit-em-up
Suit 'Em Up
girlsloveupdates
With you, my life in the palace is never lonely.
ari-dark-raiden-simp
The only true death is to never live
lostinsimsland-archive
la vie continue
officialchiki-blog
Chiki
Text
Read at - https://univest.in/hindalco-q1fy23-results-delivers-all-time-highest-quarterly-revenues-and-profits/
0 notes
Text
Aurobindo Pharma Q1FY23 profitability affected due to Margin Pressures as result of higher Input costs
On August 12, 2022, Aurobindo Pharma released its Q1FY23 results. They revealed lower earnings than anticipated due to cost headwinds that put pressure on margins. Geographically, US business expanded well year over year, while EU business remained subdued. Since the start of 2022, the Aurobindo share has undergone a significant technical correction. After the release of the Q1FY23 statistics, it didn't move significantly in any direction. Although the company is the second-largest pharmaceutical company, the stock is currently trading at significant discounts, so let's look at their Q1FY23 figures to see if there is any opportunity for investment.
Read more at - https://univest.in/aurobindo-pharma-q1fy23-results-profitability-affected-due-to-higher-input-costs/
0 notes
Text
instagram
#tcs share price
#share price of tcs
#tcs share
#tcs stock
2 notes
·
View notes